×
About 58,872 results

ALLMedicine™ Hepatitis C Virus Center

Research & Reviews  28,265 results

Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-rela...
https://doi.org/10.1111/jgh.15538
Journal of Gastroenterology and Hepatology; Hsu WF, Tsai PC et. al.

May 8th, 2021 - It is currently unknown how hepatitis C virus (HCV) eradication with pegylated interferon and ribavirin (PR) therapy affects the incidence of new-onset liver cirrhosis (LC) in patients without cirrhosis and the incidence of decompensated liver dis...

Transplant of a Kidney from a Hepatitis C Viremic Donor to a Naïve Recipient without Vi...
https://doi.org/10.12659/AJCR.927532
The American Journal of Case Reports; Rawashdeh B, Hulse J et. al.

May 6th, 2021 - BACKGROUND Kidneys from deceased donors who were positive for hepatitis C virus (HCV) on a nucleic acid amplification test (NAT) are not given to anti-HCV antibody-negative recipients. This is because of the high risk of HCV transmission, combined...

The genotype analysis of the hepatitis C virus in Heilongjiang Province, China.
https://doi.org/10.1097/MD.0000000000025203
Medicine Cheng XD, Xu HF et. al.

May 5th, 2021 - Introduction: Hepatitis C virus (HCV) infection is a major public health issue. HCV genotype identification is clinically important to tailor the dosage and duration of treatment, and recombination in intra-patient populations of HCV may lead to t...

Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model i...
https://doi.org/10.1053/j.ajkd.2021.03.017
American Journal of Kidney Diseases : the Official Journa... Hu TH, Su WW et. al.

May 3rd, 2021 - Hemodialysis facilities are high-risk environments for hepatitis C virus (HCV). Eliminating HCV from all dialysis facilities in a community may be achieved more effectively under a collaborative care model. Quality improvement study of multidiscip...

Elbasvir/grazoprevir administered for 12 weeks via Percutaneous Endoscopic Gastrostomy ...
https://doi.org/10.1002/phar.2531
Pharmacotherapy Shah RB, Garrett KL et. al.

May 2nd, 2021 - Enteral tubes are necessary for certain patients; however, medication absorption can be affected by this route of administration potentially resulting in decreased efficacy. All first-line treatments for Hepatitis C Virus (HCV) infections are only...

see more →

Guidelines  49 results

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
https://annals.org/aim/fullarticle/2751913/prevention-diagnosis-evaluation-treatment-hepatitis-c-virus-infection-chronic-kidney

Sep 23rd, 2019 - Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is an extensive updat...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chro...
https://doi.org/10.7326/M19-1539
Annals of Internal Medicine; Gordon CE, Berenguer MC et. al.

Sep 23rd, 2019 - This article has been corrected. The original version (PDF) is appended to this article as a Supplement. The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatmen...

FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrence-serious-liver-injury-use-hepatitis-c-medicines-mavyret-zepatier-and

Aug 27th, 2019 - The Food and Drug Administration (FDA) has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or li...

HIV and Viral Hepatitis - CDC
https://www.cdc.gov/hiv/pdf/library/factsheets/hiv-viral-hepatitis.pdf

Jun 26th, 2019 - People with HIV infection are affected disproportionally by viral hepatitis. Nearly 75% of people with HIV who report a history of injection drug use also are infected with hepatitis C virus (HCV).

see more →

Drugs  33 results see all →

Clinicaltrials.gov  29,225 results

Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-rela...
https://doi.org/10.1111/jgh.15538
Journal of Gastroenterology and Hepatology; Hsu WF, Tsai PC et. al.

May 8th, 2021 - It is currently unknown how hepatitis C virus (HCV) eradication with pegylated interferon and ribavirin (PR) therapy affects the incidence of new-onset liver cirrhosis (LC) in patients without cirrhosis and the incidence of decompensated liver dis...

Transplant of a Kidney from a Hepatitis C Viremic Donor to a Naïve Recipient without Vi...
https://doi.org/10.12659/AJCR.927532
The American Journal of Case Reports; Rawashdeh B, Hulse J et. al.

May 6th, 2021 - BACKGROUND Kidneys from deceased donors who were positive for hepatitis C virus (HCV) on a nucleic acid amplification test (NAT) are not given to anti-HCV antibody-negative recipients. This is because of the high risk of HCV transmission, combined...

The genotype analysis of the hepatitis C virus in Heilongjiang Province, China.
https://doi.org/10.1097/MD.0000000000025203
Medicine Cheng XD, Xu HF et. al.

May 5th, 2021 - Introduction: Hepatitis C virus (HCV) infection is a major public health issue. HCV genotype identification is clinically important to tailor the dosage and duration of treatment, and recombination in intra-patient populations of HCV may lead to t...

Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model i...
https://doi.org/10.1053/j.ajkd.2021.03.017
American Journal of Kidney Diseases : the Official Journa... Hu TH, Su WW et. al.

May 3rd, 2021 - Hemodialysis facilities are high-risk environments for hepatitis C virus (HCV). Eliminating HCV from all dialysis facilities in a community may be achieved more effectively under a collaborative care model. Quality improvement study of multidiscip...

Elbasvir/grazoprevir administered for 12 weeks via Percutaneous Endoscopic Gastrostomy ...
https://doi.org/10.1002/phar.2531
Pharmacotherapy Shah RB, Garrett KL et. al.

May 2nd, 2021 - Enteral tubes are necessary for certain patients; however, medication absorption can be affected by this route of administration potentially resulting in decreased efficacy. All first-line treatments for Hepatitis C Virus (HCV) infections are only...

see more →

News  1,297 results

Hepatitis C Drugs Work Synergistically With Remdesivir
https://www.medscape.com/viewarticle/950322

May 2nd, 2021 - (Reuters) - Combining Gilead Sciences' antiviral drug remdesivir - the current standard of care for hospitalized COVID-19 patients - with oral drugs used to treat hepatitis C virus (HCV) might be more effective than remdesivir alone, laboratory ex...

Ravidasvir-Sofosbuvir Combo Shows Promise in Chronic Hep C Infection
https://www.medscape.com/viewarticle/950088

Apr 28th, 2021 - NEW YORK (Reuters Health) - A combination of ravidasvir and sofosbuvir appears to be an effective treatment for chronic hepatitis C virus (HCV) infection across a diverse pool of patients who took part in the first half of the single-arm STORM-C-1...

Lessons Learned During COVID-19 Will Help Us Better Treat HCV
https://www.medscape.com/viewarticle/949304

Apr 20th, 2021 - If the pandemic can be said to have any silver lining, it is that the rapid transition to telehepatology services allowed us to freshly address some of the key challenges that preceded it. Nowhere has this been more apparent than in our ability to...

New 'Minimal Monitoring' Approach to HCV Treatment May Simplify Care
https://www.medscape.com/viewarticle/947455

Mar 14th, 2021 - A novel minimal monitoring (MINMON) approach to hepatitis C virus (HCV) treatment was safe and achieved sustained virology response (SVR) compared to current clinical standards in treatment-naive patients without evidence of decompensated cirrhosi...

HCV Declines Level Off in HIV+ Men Who Have Sex With Men
https://www.medscape.com/viewarticle/943804

Jan 10th, 2021 - NEW YORK (Reuters Health) - The incidence of hepatitis C virus (HCV) infection among HIV-positive men who have sex with men in the Netherlands fell once direct-acting antivirals (DAAs) became universally available in 2015, new findings show. While...

see more →

Patient Education  3 results see all →